Maria Svenvik

Publications

2024

Maria Svenvik, Johanna Raffetseder, Lars Brudin, Göran Berg, Sandra Hellberg, Marie Blomberg, Maria C. Jenmalm, Jan Ernerudh (2024) Early prediction of spontaneous preterm birth before 34 gestational weeks based on a combination of inflammation-associated plasma proteins Frontiers in Immunology, Vol. 15, Article 1415016 (Article in journal) Continue to DOI

2023

Alberto Zenere, Sandra Hellberg, Georgia Papapavlou Lingehed, Maria Svenvik, Johan Mellergård, Charlotte Dahle, Magnus Vrethem, Johanna Raffetseder, Mohsen Khademi, Tomas Olsson, Marie Blomberg, Maria Jenmalm, Claudio Altafini, Mika Gustafsson, Jan Ernerudh (2023) Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls Journal of Neuroinflammation, Vol. 20, Article 98 (Article in journal) Continue to DOI

2022

Georgia Papapavlou Lingehed, Sandra Hellberg, Jesse Huang, Mohsen Khademi, Ingrid Kockum, Hanna Carlsson, Ivar Tjernberg, Maria Svenvik, Jonas Lind, Marie Blomberg, Magnus Vrethem, Johan Mellergård, Mika Gustafsson, Maria Jenmalm, Tomas Olsson, Jan Ernerudh (2022) Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy Frontiers in Immunology, Vol. 13, Article 930947 (Article in journal) Continue to DOI

Sara Carlhäll, Marie Nelson, Maria Svenvik, Daniel Axelsson, Marie Blomberg (2022) Maternal childbirth experience and time in labor: a population-based cohort study Scientific Reports, Vol. 12, Article 11930 (Article in journal) Continue to DOI

2021

Cecilia Svanberg, Rada Ellegård, Elisa Crisci, Mohammad Khalid, Ninnie Borendal Wodlin, Maria Svenvik, Sofia Nyström, Kenzie Birse, Adam Burgener, Esaki M. Shankar, Marie Larsson (2021) Correction: Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study (vol 12, 625649, 2021) Frontiers in Immunology, Vol. 12, Article 730130 (Article in journal) Continue to DOI